Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dalteparin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04623177
What this trial is testing

Thromboprophylaxis for Patients in ICU With COVID-19

Who this might be right for
Covid19Anticoagulant TherapyThrombosis
Instituto de Investigacion Sanitaria La Fe 822
Testing effectiveness (Phase 2)Study completedNCT00952380
What this trial is testing

Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients

Who this might be right for
Venous Thromboembolism
Pfizer 38
Not applicableStudy completedNCT00750451
What this trial is testing

Low Molecular Weight Heparin in Recurrent Implantation Failure

Who this might be right for
InfertilityFertilization in VitroRecurrent Implantation Failure
V.K.V. American Hospital, Istanbul
Not applicableEnded earlyNCT00564174
What this trial is testing

Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT

Who this might be right for
Recurrent Pregnancy LossAntiphospholipid Antibody Syndrome
Mount Sinai Hospital, Canada 88
Not applicableStudy completedNCT06010446
What this trial is testing

Intravenous Continuous LMWH Seems to be Safe Alternative to UFH in VV ECMO Patients

Who this might be right for
Refractory Respiratory Failure
University Hospital, Motol 43
Post-approval studies (Phase 4)Ended earlyNCT00437697
What this trial is testing

Thromboprophylaxis in Critically Ill Patients

Who this might be right for
Venous Thromboembolism
Medical University of Vienna 90
Large-scale testing (Phase 3)Study completedNCT00828776
What this trial is testing

Pharmacodynamics and Non-Clinical Inferiority of Heparin Sodium (Cristália) Compared With the Product Liquemine (Roche) in Chronic Renal Failure

Who this might be right for
Chronic Renal Failure
Azidus Brasil 62
Post-approval studies (Phase 4)Study completedNCT00187408
What this trial is testing

The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
Sunnybrook Health Sciences Centre 700
Post-approval studies (Phase 4)Study completedNCT01828697
What this trial is testing

Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy

Who this might be right for
Deep Venous ThrombosisPulmonary Embolism
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 1,110
Not applicableStudy completedNCT05541978
What this trial is testing

Thrombosis in Patients With Multiple Myeloma in an University Medical Center

Who this might be right for
Multiple MyelomaVenous ThromboembolismArterial Thromboembolism
Catalina Codreanu 140
Not applicableStudy completedNCT00264693
What this trial is testing

Pharmacokinetics of Dalteparin in Patients With Impaired Renal Function

Who this might be right for
Renal Insufficiency
Luzerner Kantonsspital 96
Not applicableStudy completedNCT00986635
What this trial is testing

Effect of Rivaroxaban on Coagulation Parameters- an ex Vivo Study

Who this might be right for
Differences in Laboratory Coagulation Parameters
Johann Wolfgang Goethe University Hospital 100
Post-approval studies (Phase 4)Study completedNCT01930396
What this trial is testing

Use of Tinzaparin for Anticoagulation in Hemodialysis

Who this might be right for
Kidney Failure, Chronic
Christine Ribic 191
Testing effectiveness (Phase 2)Study completedNCT04640181
What this trial is testing

Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT)

Who this might be right for
Covid19
St. David's HealthCare 150
Testing effectiveness (Phase 2)Ended earlyNCT01621243
What this trial is testing

M402 in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Momenta Pharmaceuticals, Inc. 128
Not applicableStudy completedNCT01803022
What this trial is testing

Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer

Who this might be right for
Venous Thromboembolism
LEO Pharma 419
Large-scale testing (Phase 3)Study completedNCT00986154
What this trial is testing

Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).

Who this might be right for
Venous ThromboembolismDeep Vein Thrombosis (DVT)Pulmonary Embolism (PE)+2 more
Daiichi Sankyo 8,292
Not applicableNot Yet RecruitingNCT07168005
What this trial is testing

Informative Video Before LMWH Postpartum - Randomized Controlled Trial

Who this might be right for
Venous Thromboembolism (VTE)Postpartum CareAnxiety
Wolfson Medical Center 160
Not applicableUnknownNCT03787641
What this trial is testing

Systematic Evaluation of Protamine Doze in Cardiac Surgery

Who this might be right for
Cardiac Surgery With Cardiopulmonary Bypass
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 100
Not applicableUnknownNCT05382481
What this trial is testing

Anti Xa Monitoring Low Molecular Weight Heparin on Prevention of Venous Thromboembolism

Who this might be right for
Venous Thromboembolism
Xuanwu Hospital, Beijing 858
Next Page